Latest period
$226M
YoY change
+63.8%
5Y CAGR
+14.7%
Peak year (FY2021)
$195M
Latest annual
$151M
Total Assets history chart for Ovid Therapeutics (OVID) from 2016 to 2025
Latest: $151M
Total Assets growth chart for Ovid Therapeutics (OVID) from 2016 to 2025
Latest: +63.8%
Total Assets history table for Ovid Therapeutics (OVID) from 2014 to 2025
| FY2025 | $151M | +63.8% | +$58.8M | ||
| FY2024 | $92.2M | -36.0% | -$51.9M | ||
| FY2023 | $144M | -7.2% | -$11.2M | ||
| FY2022 | $155M | -20.2% | -$39.3M | ||
| FY2021 | $195M | +156.2% | +$119M | ||
| FY2020 | $75.9M | -6.1% | -$4.92M | ||
| FY2019 | $80.8M | +69.7% | +$33.2M | ||
| FY2018 | $47.6M | -46.7% | -$41.8M | ||
| FY2017 | $89.5M | +68.7% | +$36.4M | ||
| FY2016 | $53M | -24.7% | -$17.3M | ||
| FY2015 | $70.4M | +1348.6% | +$65.5M | ||
| FY2014 | $4.86M | — | — |
- FY2025$151M+63.8%
- FY2024$92.2M-36.0%
- FY2023$144M-7.2%
- FY2022$155M-20.2%
- FY2021$195M+156.2%
- FY2020$75.9M-6.1%
- FY2019$80.8M+69.7%
- FY2018$47.6M-46.7%
- FY2017$89.5M+68.7%
- FY2016$53M-24.7%
- FY2015$70.4M+1348.6%
- FY2014$4.86M—
Total Assets values are taken from Ovid Therapeutics's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Ovid Therapeutics (OVID)
According to Ovid Therapeutics's latest reported financial statements, the company's latest reported total assets is $226M. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Ovid Therapeutics (OVID) reported total assets of $151M – surged 63.8% year-over-year.
Over 2020–2025 (5 years), Ovid Therapeutics total assets expanded at a +14.7% compound annual rate, with mixed annual results across the window.
Between 2021 and 2025, Ovid Therapeutics total assets declined 22.4%, falling from $195M to $151M.
2021 marks the peak total assets at $195M, with the historical low of $4.86M recorded in 2014.
Ovid Therapeutics Total Assets by Year
Ovid Therapeutics Total Assets 2025: $151M
Ovid Therapeutics total assets in 2025 was $151M, surged 63.8% from 2024.
Ovid Therapeutics Total Assets 2024: $92.2M
2024's total assets for Ovid Therapeutics came in at $92.2M, plunged 36.0% below 2023.
Ovid Therapeutics Total Assets 2023: $144M
Ovid Therapeutics posted total assets of $144M in 2023, declined 7.2% below 2022.
Ovid Therapeutics Total Assets 2022: $155M
In 2022, Ovid Therapeutics reported total assets of $155M, declined 20.2% below 2021.
Ovid Therapeutics Total Assets 2021: $195M
Ovid Therapeutics total assets in 2021 was $195M.
See more financial history for Ovid Therapeutics (OVID).
Sector peers by Total Assets
Healthcare peers of Ovid Therapeutics (OVID), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on OVID
Market Cap — 10 rounds, every one of them OVID against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Ovid Therapeutics (OVID) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.